Middle East and Africa Rare Disease Drugs Research
8 comprehensive market analysis studies and research reports on the Middle East and Africa Rare Disease Drugs sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 102 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Neuromyelitis Optica Spectrum Disorder Market
CAGR: 6.31%
Study Period : 2019 - 2030
Healthcare
Categories
8 Healthcare Reports
Categories
Filters and Sort
Showing 8 of 8 results in Rare Disease Drugs
Scleroderma Therapeutics Market
CAGR: 7.68%
Study Period: 2020 - 2031
Region Covered: Middle East and Africa
Major Players:Boehringer Ingelheim, Roche, Johnson & Johnson Services Inc. (Actelion), Bayer, Novartis
Guillain-Barre Syndrome Market
CAGR: 5.7%
Study Period: 2020 - 2031
Region Covered: Middle East and Africa
Major Players:CSL Behring, Takeda Pharmaceuticals, Grifols, Kedrion Biopharma, Octapharma
Rare Neurological Disease Treatment Market
CAGR: 6.66%
Study Period: 2022 - 2031
Region Covered: Middle East and Africa
Major Players:CSL Behring, Merz Pharma, Kedrion Biopharma, US WorldMeds, Aquestive Therapeutics
TRENDING REPORTS
Neuromyelitis Optica Spectrum Disorder Market
CAGR: 6.31%
Study Period : 2019 - 2030
Rare Disease Treatment Market
CAGR: 11.78%
Study Period: 2020 - 2031
Region Covered: Middle East and Africa
Major Players:Amgen, Biomarin Pharmaceutical, Bayer, Bristol-Myers Squibb, AstraZeneca
Alpha Mannosidosis Market
CAGR: 16.40%
Study Period: 2019 - 2030
Region Covered: Middle East and Africa
Major Players:Chiesi Farmaceutici, Sobi, Orchard Therapeutics plc, Avrobio, Ultragenyx Pharmaceutical Inc.
Hypoparathyroidism Treatment Market
CAGR: 4%
Study Period: 2019 - 2030
Region Covered: Middle East and Africa
Major Players:Roche, Teva Pharmaceutical Industries, Amgen, Zhejiang NHU, EnteraBio Ltd.
Monkeypox Vaccine and Treatment Market
CAGR: 10.1%
Study Period: 2021 - 2030
Region Covered: Middle East and Africa
Major Players:Bavarian Nordic, SIGA Technologies, Chimerix
Orphan Drugs Market
CAGR: 6.24%
Study Period: 2019 - 2030
Region Covered: Middle East and Africa
Major Players:Takeda Pharmaceuticals, Novartis, Johnson & Johnson, Roche, Bristol-Myers Squibb
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
